[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global States Cytotoxic Drug Market Research Report 2011-2023

August 2017 | 88 pages | ID: GCF7CF11ACEEN
HeyReport

US$ 2,740.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.

The global States Cytotoxic Drug market will reach Volume Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Injection
  • Solid Oral Dose Forms
  • Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Roche
  • Eli Lilly
  • Celgene
  • Sanofi
  • eisai
  • Sumitomo Dainippon Pharma
  • Merck
  • Seattle Genetics
  • Takeda
  • Haosoh Pharma
  • Novartis
  • AstraZeneca
  • Jazz Pharma
  • Spectrum Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Breast Cancer
  • Blood Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Injection
    1.2.1.2 Solid Oral Dose Forms
    1.2.1.3 Others
  1.2.2 by Application
    1.2.2.1 Breast Cancer
    1.2.2.2 Blood Cancer
    1.2.2.3 Prostate Cancer
    1.2.2.4 Respiratory/Lung Cancer
    1.2.2.5 Others
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Injection Market, 2011-2016
  4.1.2 Solid Oral Dose Forms Market, 2011-2016
  4.1.3 Others Market, 2011-2016
4.2 Market Forecast
  4.2.1 Injection Market Forecast, 2017-2022
  4.2.2 Solid Oral Dose Forms Market Forecast, 2017-2022
  4.2.3 Others Market Forecast, 2017-2022

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Breast Cancer Market, 2011-2016
  5.1.2 Blood Cancer Market, 2011-2016
  5.1.3 Prostate Cancer Market, 2011-2016
  5.1.4 Respiratory/Lung Cancer Market, 2011-2016
  5.1.5 Others Market, 2011-2016
5.2 Market Forecast
  5.2.1 Breast Cancer Market Forecast, 2017-2022
  5.2.2 Blood Cancer Market Forecast, 2017-2022
  5.2.3 Prostate Cancer Market Forecast, 2017-2022
  5.2.4 Respiratory/Lung Cancer Market Forecast, 2017-2022
  5.2.5 Others Market Forecast, 2017-2022

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2011-2016
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2011-2016
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2011-2016
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2011-2016
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2011-2016
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2017-2022
  6.2.2 North America Market Forecast, 2017-2022
  6.2.3 Europe Market Forecast, 2017-2022
  6.2.4 South America Market Forecast, 2017-2022
  6.2.5 Middle East & Africa Market Forecast, 2017-2022

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Roche
  8.1.2 Profile
  8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Eli Lilly
  8.2.1 Profile
  8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Celgene
  8.3.1 Profile
  8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Sanofi
  8.4.1 Profile
  8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 eisai
  8.5.1 Profile
  8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Sumitomo Dainippon Pharma
  8.6.1 Profile
  8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Merck
  8.7.1 Profile
  8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Seattle Genetics
  8.8.1 Profile
  8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Takeda
  8.9.1 Profile
  8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Haosoh Pharma
  8.10.1 Profile
  8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 Novartis
8.12 AstraZeneca
8.13 Jazz Pharma
8.14 Spectrum Pharma

9 CONCLUSION

LIST OF TABLES

Table PRODUCT SPECIFICATIONS OF STATES CYTOTOXIC DRUG
Table Products Segment of States Cytotoxic Drug
Table Injection Overview
Table Solid Oral Dose Forms Overview
Table Others Overview
Table Global States Cytotoxic Drug Market by Type, 2011-2022 (USD Million)
Table Application Segment of States Cytotoxic Drug
Table Breast Cancer Overview
Table Blood Cancer Overview
Table Prostate Cancer Overview
Table Respiratory/Lung Cancer Overview
Table Others Overview
Table Global States Cytotoxic Drug Market by Application, 2011-2022 (USD Million)
Table Global States Cytotoxic Drug Market by Region, 2011-2022 (USD Million)
Table Cost of States Cytotoxic Drug
Table Market Dynamics
Table Policy of States Cytotoxic Drug
Table GDP of Major Countries
Table Injection CAGR by Revenue and Volume, 2011-2016
Table Solid Oral Dose Forms CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
Table Injection CAGR by Revenue and Volume, 2012-2022
Table Solid Oral Dose Forms CAGR by Revenue and Volume, 2012-2022
Table Others CAGR by Revenue and Volume, 2012-2022
Table Breast Cancer CAGR by Revenue and Volume, 2011-2016
Table Blood Cancer CAGR by Revenue and Volume, 2011-2016
Table Prostate Cancer CAGR by Revenue and Volume, 2011-2016
Table Respiratory/Lung Cancer CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016

LIST OF FIGURES

Figure States Cytotoxic Drug Picture
Figure Industry Chain Structure of States Cytotoxic Drug
Figure SWOT of States Cytotoxic Drug
Figure Injection Market Size and Growth, 2011-2016 (USD Million)
Figure Injection Market Size and Growth, 2011-2016 (in Volume)
Figure Solid Oral Dose Forms Market Size and Growth, 2011-2016 (USD Million)
Figure Solid Oral Dose Forms Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Injection Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Injection Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Solid Oral Dose Forms Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Solid Oral Dose Forms Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Breast Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Breast Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Blood Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Blood Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Prostate Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Prostate Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Respiratory/Lung Cancer Market Size and Growth, 2011-2016 (USD Million)
Figure Respiratory/Lung Cancer Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Breast Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Breast Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Blood Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Blood Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Prostate Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Prostate Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Respiratory/Lung Cancer Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Respiratory/Lung Cancer Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure States Cytotoxic Drug Market Concentration by Region
Figure Marketing Channels Overview


More Publications